Development/clinical chemistry

Hot off the press, mutagenic etc impurities and limits in API design:

https://pubs.acs.org/doi/pdf/10.1021/acs.oprd.0c00343

Another paper, might be of importance in terms of timing/potency/possible resitance of any antiviral interventions: